SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039904
Filing Date
2023-05-15
Accepted
2023-05-15 17:00:46
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_gamida.htm   iXBRL 10-Q 963178
2 CERTIFICATION f10q0323ex31-1_gamida.htm EX-31.1 13223
3 CERTIFICATION f10q0323ex31-2_gamida.htm EX-31.2 12892
4 CERTIFICATION f10q0323ex32-1_gamida.htm EX-32.1 4977
  Complete submission text file 0001213900-23-039904.txt   3865091

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gmda-20230331.xsd EX-101.SCH 39570
6 XBRL CALCULATION FILE gmda-20230331_cal.xml EX-101.CAL 34756
7 XBRL DEFINITION FILE gmda-20230331_def.xml EX-101.DEF 176907
8 XBRL LABEL FILE gmda-20230331_lab.xml EX-101.LAB 366922
9 XBRL PRESENTATION FILE gmda-20230331_pre.xml EX-101.PRE 190771
51 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_gamida_htm.xml XML 261124
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38716 | Film No.: 23923943
SIC: 2836 Biological Products, (No Diagnostic Substances)